Error: Could not add to watchlist. X

Thallion Pharmaceuticals Inc

+ Watchlist
TLN:CN
Acquired
TLN:CN was acquired by BLU:CN
CAD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
0.06
Market Cap (CAD)
-
Shares Outstanding (m)
32.195
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Thallion Pharmaceuticals Inc. is a biotechnology company that develops and markets drugs that can treat cancer and infectious diseases.
ADDRESS
1375 TransCanada Highway
Suite 200
Dorval, QC H9P 2W8
Canada
PHONE
1-514-940-3600
  • Allan Mandelzys
    Chief Executive Officer
Show More